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Target of rapamycin (TOR) is an evolutionarily conserved nutrient-sensing protein kinase that regulates
growth and metabolism in all eukaryotic cells. Studies in flies, worms, yeast, and mice support the notion
that the TOR signaling network modulates aging. TOR is also emerging as a robust mediator of the protective
effects of various forms of dietary restriction (DR), which can extend life span and slow the onset of certain
age-related diseases across species. Here we discuss how modulating TOR signaling slows aging through
downstream processes including mRNA translation, autophagy, endoplasmic reticulum (ER) stress
signaling, stress responses, and metabolism. Identifying the mechanisms by which the TOR signaling
network works as a pacemaker of aging is a major challenge and may help identify potential drug targets
for age-related diseases, thereby facilitating healthful life span extension in humans.Introduction
TOR belongs to a conserved group of serine/threonine kinases
from the phosphatidylinositol kinase-related kinase (PIKK)
family. Rapamycin, an immunosuppressive macrolide that was
first discovered as the product of the bacterium Streptomyces
hygroscopicus from Easter Island (Rapa Nui), inhibits the activity
of TOR (Heitman et al., 1991). TOR, first identified in yeast and
since then in all eukaryotes examined, exists in two distinct
complexes with different functions (Martin and Hall, 2005).
TOR complex 1 (TORC1) is rapamycin sensitive and is the central
element of the TOR signaling network (Figure 1). It monitors and
integrates a diverse set of intra- and extracellular parameters
and controls cell size, proliferation, and life span via a variety
of downstream pathways. It is composed of the serine/threonine
kinase TOR and its associated proteins Raptor (regulatory
associated protein of TOR), mLst8, PRAS40, and, in mammals,
Deptor (Guertin and Sabatini, 2005, 2009; Wullschleger et al.,
2006). On the other hand, TOR complex 2 (TORC2) is rapamycin
insensitive and controls the activity of serum- and glucocorti-
coid-induced kinase (SGK) and contributes to the full activation
of Akt (Alessi et al., 2009). It contains TOR, Rictor (rapamycin-
insensitive companion of mTOR), Sin1, Proctor/PRR5L, mLst8,
and (again, only in mammals) Deptor (Guertin and Sabatini,
2005, 2009; Wullschleger et al., 2006).
The TOR signaling network can be schematized by connecting
discrete signaling modules sensing and relaying diverse inputs
to a central ‘‘signaling core’’ (Figure 1). This core consists of
the serine/threonine kinase Akt, the tuberous sclerosis complex
proteins Tsc1 and Tsc2, the Ras-like small GTPase Rheb, and
TORC1 itself. In mammals, the activity of TORC1 is held in check
by three inhibitory elements within this cascade: the Tsc1/Tsc2
complex, PRAS40, and Deptor (Peterson et al., 2009). The
biochemical nature of how the signal cascades though the
pathway has been exquisitely reviewed and is only summarized
here (Guertin and Sabatini, 2009; Shamji et al., 2003; Shaw and
Cantley, 2006; Wullschleger et al., 2006). In short, the activationof the TORC1 signaling core occurs by an Akt-driven derepres-
sion mechanism. Once activated by upstream signals, Akt phos-
phorylates and inhibits the negative regulators Tsc2 and
PRAS40, which then activates the GTPase Rheb and releases
TORC1 from inhibition.
Despite the evolutionary conservation of individual compo-
nents of the TOR pathway, some significant differences exist
between species. Of note, baker’s yeast (S. cerevisiae) and
fission yeast (S. pombe) contain two genes encoding TOR,which
are differentially incorporated into the distinct TORC complexes
(Loewith et al., 2002). However, S. pombe hosts genes for the
Rheb GTPase and the Tsc1/Tsc2 complex, while S. cerevisiae
does not. The nematodeC. elegans lacks a functional equivalent
to the Tsc1/Tsc2 complex but connects the activity of Akt and
TORC1 by Akt-dependent transcriptional regulation of Raptor
(Jia et al., 2004; Wullschleger et al., 2006). Despite these differ-
ences, the TOR signaling network controls a conserved set of
physiological processes in multiple species (see below).
TOR Plays a Conserved Role in Coupling Nutrients
to Growth
Since its discovery as a regulator of growth in S. cerevisiae, TOR
has been shown to be a conserved nutrient sensor across
species. This has been reflected in the common loss-of-function
phenotypes of TOR in multiple species. In C. elegans, deletion of
CeTOR leads to developmental arrest at the L3 larval stage and
intestinal atrophy (Long et al., 2002). A similar phenotype was
observed for mutants in daf-15, the worm ortholog of the
mammalian protein raptor (Jia et al., 2004). In D. melanogaster,
larvae lacking TOR show similarities to amino acid-deprived
animals, such as developmental arrest, reduced nucleolar size,
and lipid vesicle aggregation in the larval fat body (Oldham
et al., 2000; Zhang et al., 2000). Similar to invertebrates, loss of
function ofmammalian TOR (mTOR) inmice leads to early embry-
onic lethality (Hentges et al., 2001; Murakami et al., 2004). The
tissue-specific removal of raptor in skeletal muscle inducesCell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc. 453
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Figure 1. Schematic of the TOR Signaling Network
TORC1 integrates intra- and extracellular environmental cues through discrete signaling modules that sense and relay diverse inputs to a central ‘‘signaling core’’
(in green). This figure summarizes biochemical evidence from various studies that have identified the inputs and outputs of TORC1. Various outputs (in gray) that
keep cellular growth in balance with the environment are regulated by TORC1. See the main text for details.
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Reviewprogressive muscle dystrophy, which is likely due to impaired
protein synthesis (Bentzinger et al., 2008). Thus, mutations in
TOR show developmental or growth arrest phenotypes in
different species, comparable to those observed upon nutrient
deprivation, supporting the notion that it has a conserved role in
coupling of availability of nutrients to growth in multiple species.
TOR Integrates Extra- and Intracellular Signals from
Nutrients, Growth Factors, and Various Stresses
In addition to playing a conserved role as a common nutrient
sensor, TORC1 acts as a major hub integrating signals
emanating from a variety of sources and influencing multiple
physiological responses (Figure 1). TORC1 receives signals
from growth factors, nutrients, energy status, and a range of
stressors. This has led to the view that TOR signaling serves as
a ‘‘growth checkpoint,’’ surveying the extra and intracellular
milieu for favorable conditions to mediate growth accordingly
(Shaw and Cantley, 2006). This ability to balance a multitude of
signals is reflected in the number of signaling modules linked
to the central signaling core (Figure 1). Multiple inputs are inte-
grated and relayed toward the regulation of a number of down-
stream pathways. TORC1 activity influences mRNA translation,
autophagy, transcription, metabolism and cell survival, prolifera-
tion, size, and growth, in addition to a number of other cellular
processes. An accumulating body of data suggests that some
of these responses influence organismal life span.
To ensure that growth rates match resources, both the quality
and quantity of the nutrient status need to be assessed and inte-
grated. It seems that the eukaryotic cell has solved this problem
by utilizing the TOR signaling network as an important check-
point (Figure 1). Withdrawal of amino acids acts as a powerful
inhibitor of TORC1 activity, even in the presence of acute growth
factor stimulation (Hara et al., 1998). Essential amino acids like
L-tryptophan, L-phenylalanine, L-arginine, and especially
L-leucine activate TORC1 after being transported into the cell
in an L-glutamine-dependent manner (Nicklin et al., 2009). While
it remains unclear how amino acid sufficiency is sensed within
the cytoplasm of the cell, two small heterodimeric GTPases,
RagA/RagC and RagB/RagD, have been shown to relay the
signal of amino acid sufficiency to TORC1 (Kim et al., 2008; San-
cak et al., 2008). TOR also responds to the energy charge within
the cell, which is influenced by the presence of nutrients like
glucose. A drop in the cell’s energy content is reflected in the
rise of the AMP/ATP ratio and triggers AMP-dependent activa-
tion of AMP-dependent kinase (AMPK) (Hardie, 2007). In turn,
AMPK reduces the activity of the TOR signaling core by direct
phosphorylation on two key proteins: it phosphorylates and
stimulates Tsc2 activity, and further reduces TORC1 by inhibi-
tory Raptor phosphorylation (Gwinn et al., 2008). In addition to
nitrogen starvation, carbon and phosphate starvation also lead
to inhibition of TORC1 in S. cerevisiae (Kuruvilla et al., 2001;
Shamji et al., 2000; Urban et al., 2007). Hence, the TOR pathway
integrates information on cellular status by sensing both qualita-
tive and quantitative changes in nutrients.
As noted above, unicellular organisms sense and directly
respond to the presence or absence of nutrients, such as amino
acids and glucose, to control growth. In multicellular organisms,
the requirement for coordination of growth in different tissues
creates a need for intercellular communication, which isachieved by diffusible growth factors. In order to gauge the
appropriateness of these growth signals, multicellular organisms
have evolved to integrate various growth factors and direct
nutrient inputs. The role of TORC1 as a major hub for integration
of control of growth is supported by the observations that its
activity is modulated by various growth-signaling pathways.
Growth factors like IGF and insulin modulate TORC1 activity
through Akt. Wnt signaling has also been demonstrated to
regulate TORC1 activity (Inoki and Guan, 2006). Stimulation of
the Wnt receptors culminates in the inhibition of glycogen syn-
thase kinase 3 (Gsk3). When active, Gsk3 has been shown to
directly phosphorylate and activate Tsc2 when primed by
AMPK-dependent phosphorylation (Inoki et al., 2006). Therefore,
Wnt-mediated inactivation of Gsk3 alleviates Tsc2-driven inhibi-
tion of Rheb and results in TORC1 activation. Inputs from various
other growth factors, like that from transforming growth factor
(TGF) b (Lamouille and Derynck, 2007), further endorse TORC1’s
role in sensing extracellular growth status.
In addition to nutrients and growth factors, appropriate control
of cell growth also requires integration of information on environ-
mental stresses. Hence, it is not surprising that multiple stresses
also modulate TORC1 activity. TORC1 is rendered less active by
high temperature, hydrogen peroxide, and high salt stress in S.
cerevisiae (Urban et al., 2007). Correspondingly, osmotic stress
inactivates TORC1 by modulating mitochondrial function (Desai
et al., 2002). TORC1 also responds to hypoxia. Low oxygen
levels stabilize HIF1a, allowing the formation of a heterodimer
with the aryl hydrocarbon receptor nuclear translocator
(ARNT). The HIF1a/ARNT dimer activates the transcription of
hypoxic response genes, most notably REDD1 that inhibits
TORC1 activity by a TSC2-dependent mechanism (Brugarolas
et al., 2004; Reiling and Hafen, 2004). Genotoxic stress has
also been shown to inhibit TORC1. Sestrin1 and Sestrin2, both
transcriptional targets of the DNA damage sensor p53, activate
AMPK, thereby inhibiting TOR pathway activity (Budanov and
Karin, 2008). Hence, sensing of inputs from nutrients, growth
factors, and cellular stress signals uniquely positions TORC1 to
synchronize growth in tune with its environment.
In summary, the TOR signaling network integrates information
from a variety of inhibitory and stimulatory environmental signals.
Some of the key questions in the field include the following: (1)
How are multiple nutrients, growth factors, and stress inputs
quantitatively integrated into a single TORC1 activity level? (2)
Are the physiological responses downstream of TORC1 differen-
tially regulated by TORC1 activity, and if yes, how so? and (3)
How does TOR mediate changes in survival and life span in
response to various environmental manipulations, especially
nutrients? In the rest of this article we will discuss the emerging
evidence for this final question, which has become of growing
interest and may also help illuminate the role of TOR in various
human diseases.
The TOR Signaling Network Mediates the Protective
Effects of Dietary Restriction in Different Species
Aging is the single largest risk factor for disease in developed
countries and arguably the single greatest challenge for biomed-
icine. Dietary restriction (DR) is the most robust environmental
method to slow down aging in species as diverse as yeast,
worms, fruit flies, rodents (Masoro, 2003), and recently evenCell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc. 455
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most age-related diseases, including some cancers, neurode-
generation, and cardiovascular diseases (Masoro, 2003). DR is
classically defined as a reduction of particular or total nutrient
intake without causing malnutrition. In practice, DR is applied
as an overall reduction of the caloric intake (calorie restriction),
the restriction of a particular class of nutrients, temporal varia-
tions of food intake, or combinations thereof. Due to its robust-
ness and strong conservation across species, identifying the
molecular mechanisms that modulate life span upon DR holds
great promise for providing insight into themechanisms of aging.
Examination of the molecular and genetic foundation of this
protective response is moving at a feverish pace in the last few
years. This has been made possible largely due to the short life
span and powerful genetic tools that are available in S. cerevi-
siae, C. elegans, and D. melanogaster. One of the proposed
evolutionary mechanisms of DR is that under conditions of
nutrient limitation, there is a shift in metabolic investment from
reproduction and growth toward somatic maintenance to ensure
extended survival (Holliday, 1989). Abundant evidence for
TORC1 as a conserved nutrient sensor makes it an attractive
candidate to mediate this switch between growth and somatic
maintenance to extend life span by DR.
In S. cerevisiae, DR due to limitation of glucose has been
shown to robustly extend life span. Replicative life span,
measured by the number of replication events from a single
mother yeast cell, is increased when TOR activity is diminished.
Furthermore, lowering glucose levels did not further extend life
span of a tor1 deletion mutant (Kaeberlein et al., 2005). Hence,
the TOR pathway mediates life span extension by DR imposed
by limiting glucose concentrations in S. cerevisiae. Inhibition of
TOR also extends yeast chronological life span (CLS), which
measures the ability of stationary (in the absence of nutrients)
cultures to maintain viability over time (Bonawitz et al., 2007;
Powers et al., 2006).
Various components of the TOR signaling network have also
been shown to mediate life span extension by DR imposed by
different methods in C. elegans. Downregulation of TOR expres-
sion by RNAi in C. elegans during adulthood results in life span
extension (Vellai et al., 2003). This effect is independent of the
FOXO ortholog DAF-16 (Vellai et al., 2003), a transcription factor
that is required to mediate the life span extension caused by
reduced insulin-like signaling (ILS) pathway activity (Guarente
and Kenyon, 2000). Heterozygous daf-15mutants, the worm or-
tholog of the mammalian protein raptor, display an extended life
span, again lending credence to the hypothesis that partial inhi-
bition of TORC1 activity suffices to extend life span in model
organisms (Jia et al., 2004). Genes in the TOR pathway have
been implicated in mediating the life span extension imposed
by reducing bacterial food concentration in the diet of C. elegans
(Chen et al., 2009b; Honjoh et al., 2009). In a model distinct from
reducing available food, the eat-2 mutation, which causes
pharyngeal pumping defects in C. elegans, has been proposed
to extend life span by eliciting a DR-like response (Lakowski
and Hekimi, 1998). Additional inhibition of the TOR pathway
and its downstream genes in an eat-2 mutant background
does not further extend life span, suggesting that DR and low-
ered TORC1 signaling act by overlapping mechanisms (Chen
et al., 2009b; Hansen et al., 2008).456 Cell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc.InD. melanogaster, restriction of total food yields extended life
span (Clancy et al., 2002; Mair et al., 2003; Rogina et al., 2002).
A number of groups have shown that reducing yeast (the major
source of protein in the fly diet) alone is also sufficient to extend
life span in D. melanogaster (Chippindale et al., 1993; Kapahi
et al., 2004; Mair et al., 2005). Overexpression of either Tsc1 or
Tsc2, or dominant-negative forms of dTOR, extends life span
in D. melanogaster (Kapahi et al., 2004). Fat and muscle were
observed to be the key tissues responsible for the life span
extension effects of inhibiting TOR signaling in D. melanogaster
(Kapahi et al., 2004). Under conditions of DR imposed by restrict-
ing dietary yeast, inhibition of the TOR pathway resulted in no
further extension of life span. These findings support the idea
that TOR mediates life span extension by DR in flies (Kapahi
et al., 2004).
The role of the TOR signaling network inmediatingmammalian
aging phenotypes is also beginning to emerge. Long-lived Ames
dwarf mice harbor mutations in a gene called Prop-1 that
disrupts pituitary gland development (Bartke and Brown-Borg,
2004; Brown-Borg, 2009). It has been proposed that these
mice show reduced protein synthesis possibly via inhibition of
TOR signaling (Sharp and Bartke, 2005). These data support
the notion that reduced signaling downstream of TOR extends
life span in mice. The National Institute on Aging initiated the
Interventions Testing Program (ITP) to evaluate drugs that puta-
tively delay aging or prevent multiple forms of late-life disease in
laboratorymice in three different laboratories. The administration
of the TORC1 inhibitor rapamycin late in life (aged 600 days) was
sufficient to cause a life span extension at all three sites (p < 0.05)
in both sexes, although there are sex-specific differences (males
9%, females 13%) (Harrison et al., 2009). A second study also
demonstrated that rapamycin treatment initiated past middle
age (22–24 months old) increases life span in mice. This study
also showed that under these conditions, rapamycin treatment
can boost immune function and rejuvenate hematopoietic stem
cells (Chen et al., 2009a). The role of TORC1 has also been tested
in models of cellular senescence in culture. Notably, the effects
of Doxorubicin (DOX), a DNA-damaging agent mediating cellular
senescence in normal human cells, were rescued by treatment
with rapamycin (Demidenko and Blagosklonny, 2008). Together
these data give promise to the notion that reduced TORC1
signaling may extend life span even in mammals.
These data emphasize the importance of TORC1 activity in
mediating life span extension in multiple species and under
different methods of nutrient manipulation. TORC2 plays a minor
role in modulating life span. A study using C. elegans demon-
strated that a mutant in Rictor shows life span shortening on
feeding standard bacteria but extends life span when fed certain
types of nutrient-rich bacteria (Soukas et al., 2009). The
discovery that the TOR signaling network mediates life span
extension caused by nutrient modulation in invertebrate and
vertebrate species provides a framework to examine the genetic
and molecular basis of how DR extends life span. Strong inhibi-
tion of TORC1 early in life (embryogenesis or larval stages) dras-
tically slows or even stops development. In contrast, inhibition of
this pathway during adulthood (late life) extends life span. This is
consistent with the predictions of the theory of antagonistic
pleiotropy, which suggests that genes that are important for
fitness early in life limit survival later in life (Williams, 1957).
Table 1. Components of the TOR Pathway that Modulate Life Span in Various Species
Model System Dietary Manipulation/Assay Proteins Implicated Reference
M. musculus None TOR (Harrison et al., 2009)
M. musculus None S6K (Selman et al., 2009)
D. melanogaster Yeast restriction TOR, TSC1, TSC2, S6K (Kapahi et al., 2004)
D. melanogaster Yeast restriction 4E-BP, mitochondrial ETC (Zid et al., 2009)
C. elegans None TOR (Vellai et al., 2003)
C. elegans None Raptor (Jia et al., 2004)
C. elegans None S6K, eIF4F complex (Pan et al., 2007)
C. elegans None Translation factors, ribosomal proteins (Hansen et al., 2007)
C. elegans None eIF4E (Syntichaki et al., 2007)
C. elegans None Translation factors, ribosomal proteins (Curran and Ruvkun, 2007)
C. elegans Bacterial restriction AMPK, DAF-16 (Greer et al., 2007)
C. elegans None Translation factors, ribosomal proteins (Chen et al., 2007)
C. elegans None autophagy (Hansen et al., 2008)
C. elegans None S6K, PHA-4 (Sheaffer et al., 2008)
C. elegans None DAF-15, autophagy (Toth et al., 2008)
C. elegans Intermittent fasting RHEB-1, DAF-16 (Honjoh et al., 2009)
C. elegans Bacterial restriction S6K, HIF-1, EGL-9, IRE-1, Raptor (Chen et al., 2009b)
C. elegans None TOR-interacting proteins (Bell et al., 2009)
S. cerevisiae Glucose restriction (replicative life span) TOR, SCH9 (Kaeberlein et al., 2005)
S. cerevisiae Glucose restriction (chronological life span) Mitochondrial ETC genes (Bonawitz et al., 2007)
S. cerevisiae Glucose restriction (replicative life span) TOR, MSN2, MSN4, PNC1 (Medvedik et al., 2007)
S. cerevisiae Glucose restriction (replicative life span) GCN4, 60S ribosomal subunit, TOR (Steffen et al., 2008)
S. cerevisiae Glucose restriction (chronological life span) TOR, SCH9, RIM15, MSN2/4, GIS1 (Wei et al., 2008)
S. cerevisiae Glucose restriction (chronological life span) TOR, SCH9, glycerol synthesis (Wei et al., 2009)
A list of studies that have demonstrated a role for genes in the TOR pathway or its interacting proteins to mediate life span extension by nutrient manip-
ulation or under standard laboratory conditions in different model systems.
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various processes downstream of TORC1 to aging, which
provides hope of achieving a more complete understanding of
how growth, development and aging are linked with each other
(Table 1, Figure 2).
Mediators of TORC1 that Modulate Life Span
Protein Synthesis
Inhibition of protein synthesis is one of the major effects medi-
ated by reducing TOR pathway activity (Ma and Blenis, 2009;
Shamji et al., 2003). The regulation of protein synthesis also plays
a crucial role in keeping organismal growth and development in
tune with environmental conditions (Sonenberg et al., 2000).
Inhibition of protein synthesis by attenuating expression of
various mRNA translation factors (Hansen et al., 2007; Hender-
son et al., 2006; Pan et al., 2007; Steffen et al., 2008; Syntichaki
et al., 2007) or reducing protein in the diet (Chippindale et al.,
1993; Kapahi et al., 2004; Miller et al., 2005; Orentreich et al.,
1993; Richie et al., 1994) extends life span in multiple species.
Furthermore, the rate of protein synthesis has been shown to
inversely correlate with longevity across species (Finch, 1990),
arguing for its role in determining species-specific life span.
The phenotypic overlap of DR and reduced translational initia-
tion suggests that inhibition of protein synthesis is also likely to
be important for the life span extension by DR. Given the high
cost of mRNA translation in a cell, a shift of investment fromcontinuing protein synthesis for growth toward more conserva-
tive somatic maintenance is conceivable under periods of DR.
It was previously believed that total calorie intake was the
most important aspect of extending life span by diet manipula-
tion. However, a number of studies over the past two decades
have demonstrated that restricting protein alone is sufficient
for life span extension. In rodents, restricting the intake of single
amino acids, such as methionine or tryptophan, yields an
extended life span comparable to restricting ad libitum feeding
(Miller et al., 2005; Orentreich et al., 1993; Richie et al., 1994;
Zimmerman et al., 2003). Although total body weight was
reduced in methionine-restricted animals, weight-normalized
food intake was actually increased (Orentreich et al., 1993).
These results suggest that a decrease in energy intake or expen-
diture on a bodyweight basis is not necessary for life span exten-
sion. In D. melanogaster, restriction of yeast, the major source of
protein in the fly diet, is sufficient to extend life span (Chippindale
et al., 1993; Kapahi et al., 2004; Mair et al., 2003). Reduction of
protein fails to extend life span in rats (Masoro et al., 1989),
and whether reduction of protein would extend life span in other
species remains to be seen. Restriction of dietary protein may
act directly on protein synthesis by reducing the pool of available
amino acids, and/or by inhibiting growth-signaling pathways like
TOR that respond to the presence of these macronutrients. The
molecular mechanisms by which TORC1 activity modulates
protein synthesis is a growing area of research (Ma and Blenis,Cell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc. 457
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Figure 2. TOR Pathway, a Conserved Mediator of Life Span Extension in Multiple Species
The diagram represents the genetic interactions in the TOR signaling network that execute life span extension in yeast, worms, flies, and mice. The diagram
summarizes the life span data for genes in the TOR signaling pathway or those that demonstrate a genetic interaction with mutants in the TOR pathway. The
shaded area refers to components of the TOR pathway that show conserved effects on life span extension in different species. See the main text for details.
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2006). Regulation of protein synthesis by TORC1 takes place
at multiple levels including modulation of S6 kinase, mRNA
translation initiation, and ribosomal biogenesis. Modulation of
mRNA translation is likely to be a major mechanism by which
TORC1 modulates life span and is discussed below.
S6 Kinase
Activation of ribosomal p70 S6 protein kinase (hereafter referred
to as S6K) by phosphorylation is one of the most well-estab-
lished downstream events in the TOR pathway. Loss of S6K
results in slowed growth and reduced body size in multiple
species including flies (Montagne et al., 1999), worms (Hansen
et al., 2007; Pan et al., 2007), and mice (Um et al., 2004). Thus,
similar to TORC1, inhibition of S6K also inhibits growth, but
unlike TORC1, S6K is not essential for development. S6K modu-
lates protein synthesis by a number of mechanisms, which has
been reviewed recently (Ma and Blenis, 2009). Inhibition of S6K
has previously been shown to extend life span in D. mela-
nogaster (Kapahi et al., 2004) and C. elegans (Hansen et al.,
2007; Pan et al., 2007). In S. cerevisiae, mutations in SCH9, a
proposed ortholog of S6K (Urban et al., 2007), have been known
to significantly extend life span (Fabrizio et al., 2001; Kaeberlein
et al., 2005). Recently, female but not male mice lacking S6K1
(the mouse genome encodes two paralogs, S6K1 and S6K2)
have been shown to display increased life span and slowed
progression of age-related pathologies (Selman et al., 2009).
The sex-specific difference, although more pronounced, is remi-
niscent of the results from the rapamycin study and might point
toward gender-dependent effects of TORC1 signaling on
longevity. Previously, it had also been shown that mice lacking
S6K1 are resistant to diet-induced obesity and show improved
insulin sensitivity (Um et al., 2004). These findings demonstrate458 Cell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc.that the longevity effects of inhibiting S6K are conserved in yeast,
worms, flies, and mice, supporting its role as a key player in the
life span extension by reduced mammalian TORC1 signaling.
Regulation of mRNA Translation Initiation
mRNA translation proceeds through coordinated phases of
initiation, elongation, and termination, with initiation being the
rate-limiting step (Sonenberg et al., 2000). TORC1 enhances
translation initiation of mRNA by inhibitory phosphorylation of
the 4E-BP (eukaryotic initiation factor eIF4E-binding protein)
family of proteins (Shamji et al., 2003). Hypophosphorylated
4E-BPs act as translational repressors by binding to the transla-
tion initiation factor eIF4E. This inhibits the activity of the eIF4F
translation initiation complex. eIF4E plays a critical role in initia-
tion by recruiting mRNAs via their 50UTRs. This is accomplished
by regulating the association of the mRNA cap-binding protein
eIF4E to the scaffold protein eIF4G, both components of the
eIF4F complex. eIF4G helps assemble the eIF4F complex by
bridging the poly(A)-binding proteins (PABPs) with eIF4E (Sonen-
berg et al., 2000). This leads to the circularization of mRNAs,
which has a synergistic effect on enhancing the rate of transla-
tion (Sonenberg et al., 2000). TORC1 also modulates eIF4F
complex activity by regulating the phosphorylation and degrada-
tion of eIF4G (Berset et al., 1998). Furthermore, given the role of
TOR in activating S6K, which also modulates mRNA translation
initiation by influencing the eIF3F complex (Ma and Blenis,
2009), TOR appears to influence mRNA translation initiation at
multiple levels.
Recently, it has been shown that 4E-BP is an important
mediator of the protective effects of DR in D. melanogaster.
DR enforced by restriction of yeast in the diet requires intact
4E-BP to cause fully extended life span (Zid et al., 2009). DR
also induces 4E-BP protein levels independently of FOXO,
Cell Metabolism
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gene expression and TORC1-dependent phosphorylation. Inter-
estingly, under complete starvation conditions 4E-BP is also up-
regulated, though in a FOXO-dependent manner, and is required
for enhanced survival under these conditions (Teleman et al.,
2005; Tettweiler et al., 2005). Overexpression of a gain-of-func-
tion form of 4E-BP, which has increased affinity for eIF4E (Miron
et al., 2001), is sufficient to extend life span under rich nutrient
conditions, but not under DR (Zid et al., 2009). Together these
experiments justify the hypothesis that 4E-BP acts as amediator
of life span extension by DR and that a gain-of-function 4E-BP
displays the hallmarks of a DR mimetic in D. melanogaster.
Studies from a number of groups have shown that inhibition of
several components of the eIF4F complex and PABPs extend life
span (Curran and Ruvkun, 2007; Hansen et al., 2007; Henderson
et al., 2006; Long et al., 2002; Pan et al., 2007; Syntichaki et al.,
2007). Inhibition of ifg-1, which encodes the C. elegans ortholog
of eIF4G, during development causes larval arrest similar to that
observed upon inhibition of TOR, while its reduced expression
during adulthood increases life span and stress resistance (Han-
sen et al., 2007; Pan et al., 2007). Inhibition of eIF4E and eIF4G
extends life span inC. elegans in a DAF-16-independent manner
(Hansen et al., 2007; Pan et al., 2007; Syntichaki et al., 2007).
These experiments suggest that reducing translational initiation
is likely to slow aging by mechanisms distinct from those that
extend life span upon inhibition of the ILS pathway. Overexpres-
sion of eIF4E has also been shown to increase cellular senes-
cence in mammalian cells as determined by b-galactosidase
staining (Ruggero et al., 2004). These results support the notion
that reduction of mRNA translation initiation by inhibition of the
eIF4F complex might be a conserved mechanism to extend life
span in multiple species.
Ribosomal Biogenesis
Ribosomal proteins play a conserved and established role in
protein synthesis and growth in various species. Ribosome pro-
duction is an energetically expensive process, and it has been
proposed that TORC1 couples nutrient availability to ribosome
production (Wullschleger et al., 2006). TORC1 signaling regu-
lates ribosome biogenesis by multiple mechanisms that are not
yet well understood (Guertin and Sabatini, 2007; Wullschleger
et al., 2006). TORC1 is known to affect the transcription of
mRNAs encoding ribosomal proteins by RNA polymerase II, as
well as the transcription of ribosomal RNAs and transfer RNAs
by RNA polymerase I and RNA polymerase III, respectively
(Wullschleger et al., 2006). In S. cerevisiae, it has been proposed
that reduced ribosomal biogenesis downstream of the TOR
signaling pathway mediates the effects of DR. This has been
supported by the observation that loss of genes encoding the
60S ribosomal subunit extends life span (Steffen et al., 2008).
Furthermore, the life span extension by DR, inhibition of
TORC1 signaling, and inhibition of 60S ribosomal subunits
employs overlapping mechanisms. Inhibition of various ribo-
somal subunits has also been shown to extend life span in
C. elegans (Bell et al., 2009; Chen et al., 2007; Curran and
Ruvkun, 2007; Hansen et al., 2007).
Mechanism of Life Span Extension by Modulating
mRNA Translation
How a reduction in protein synthesis extends life span is not
entirely intuitive. This is especially hard to reconcile given theobservation that there is a global decline in protein synthesis
with age (Finch, 1990). Two models may potentially explain the
beneficial effects of inhibiting protein synthesis. One possibility
is that a global decrease in protein synthesis may improve the
fidelity of protein synthesis. Furthermore, a decrease of overall
mRNA translation could also decrease the overall burden of mis-
folded proteins by reducing the protein traffic intracellularly.
Another possibility is that the mRNA translation of specific
mRNAs may be preserved or even enhanced under conditions
of global inhibition of protein synthesis, and that this may slow
aging. These two models are not mutually exclusive, and
accumulating evidence favoring the latter model is discussed
below.
Previous studies have pointed out the importance of
regulating mRNA translation, especially under environmental
stresses (Sonenberg et al., 2000; Sonenberg and Hinnebusch,
2007). One well-studied example is that of the transcription
factor GCN4. Upon starvation, while the global rate of protein
synthesis decreases, production of GCN4 protein increases by
an enhancement in the ribosomal loading for GCN4 mRNA.
Mechanistically, this is driven by short upstream open reading
frames in the 50UTR of this gene (Hinnebusch, 2005; Tzamarias
et al., 1989). GCN4 has been shown to contribute to the
increased life span caused by RNAi against 60S ribosomal
subunits (Steffen et al., 2008).
Methods to assess genome-wide changes in translation state
are likely to provide useful insights into how changes in mRNA
translation modulate life span. Genome-wide translational
profiling examines the number of polysomes bound to each
individual mRNA. Given that mRNA translation initiation is the
major rate-limiting step in mRNA translation, this indicates the
efficiency with which each mRNA is translated (Serikawa et al.,
2003; Zong et al., 1999). Genome-wide translational changes
revealed an increase in the ribosomal binding of certain mRNAs,
though there was an overall decrease of mRNA translation
under DR in D. melanogaster (Zid et al., 2009). Surprisingly,
a number of nuclear-encoded mitochondrial genes, including
those encoding the electron transport chain (ETC) complexes
I and IV and mitochondrial ribosomal proteins, displayed
increased ribosomal binding and mRNA translation (Zid et al.,
2009). The enhanced ribosomal loading of nuclear-encoded
mitochondrial genes was dependent on their simple 50UTR
structures. These results suggest a novel mode of regulation of
nuclear-encoded mitochondrial genes by enhanced mRNA
translation under DR. However, the precise mechanisms by
which the translation machinery upregulates these genes remain
to be elucidated.
The effects of protein synthesis inhibition in different model
systems provide a novel paradigm to explore the mechanisms
of aging and DR. However, in addition to assessing the mRNA
translation state of each mRNA, information on the half-lives of
each mRNA, their elongation rates, and their turnover once
converted to protein will provide novel insights into howmodula-
tion of mRNA translation and protein synthesis alter the rate
of aging.
Stress Responses and Transcription Factors
DR and a number of long-lived mutants enhance resistance to
various environmental stresses (Martin et al., 1996; Masoro,Cell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc. 459
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lished to contribute to life span extension in multiple species
(Martin et al., 1996). As mentioned above, a similar array of
stresses alsomodulates TORC1 activity. This poses the question
of whether reduced TORC1 activity triggers a stress-resistance
response. Inhibition of the TOR signaling network and also
a number of translation factor genes enhances resistance to
various environmental stresses (Hansen et al., 2007; Kaeberlein
et al., 2005; Pan et al., 2007; Powers et al., 2006). Evidence
frombothC. elegans andS. cerevisae suggests that transcription
factors involved in mediating stress responses are regulated by
TORC1 signaling and mediate its effects on life span extension.
InC. elegans, the transcription factor PHA-4 plays an essential
role in the embryonic development of the foregut (Mango, 2009).
The mammalian orthologs of PHA-4, the Foxa transcription
factors Foxa1, Foxa2, and Foxa3, also play important roles
during development, and act later in life to regulate glucagon
production and glucose homeostasis in response to fasting
(Mair and Dillin, 2008). The interaction between PHA-4 and
TOR signaling has been uncovered by the finding that inactiva-
tion of let-363/tor or rsks-1/s6k can suppress the lethality asso-
ciated with pha-4 mutants in C. elegans (Sheaffer et al., 2008)
Furthermore, life span extension by inhibition of S6K was depen-
dent on pha-4 (Sheaffer et al., 2008). PHA-4 has previously been
described as a critical regulator of life span extension mediated
by DR but not other longevity pathways in C. elegans (Panowski
et al., 2007). Together, these findings argue for the role of S6K in
mediating life span extension by DR through PHA-4-dependent
mechanisms.
AMPK is the central player that becomes activated upon an
increased AMP/ATP ratio, indicating a reduced energy load in
the cell. While biochemical evidence places AMPK upstream to
TORC1 (Figure 1), their relationship in life span regulation is
more complex (Figure 2). It has been shown that AMPK acts
downstream of S6K and mediates the S6K-dependent effects
on body size and life span (Selman et al., 2009). In C. elegans,
loss of AMPK in a S6K mutant background reverts the body
size and fecundity defects of the S6K mutant. Though biochem-
ical data demonstrating that AMPK is a direct target of S6K are
lacking, the above results place AMPK downstream of S6K in
terms of mediating its effects on growth as well as life span.
However, this apparently counterintuitive result can be recon-
ciled by findings that both in mice and in worms loss of S6K
causes increased AMPK activity (Aguilar et al., 2007; Selman
et al., 2009). Hence, when DR causes a reduction of TORC1
and S6K, AMPK may become active and lead to sustained
TORC1 inhibition. This model suggests that AMPK, TORC1,
and S6K1 constitute a feedback signaling loop that resets its
activity upon DR to redirect growth, metabolism, and life span.
AMPK has also been proposed to be an important mediator of
the life span extension by DR imposed by dilution of bacteria in
the food (Greer et al., 2007). Furthermore, the AMPK agonist,
metformin, extends life span in at least one genetic strain of
mice (Anisimov et al., 2008). Despite the tight biochemical and
phenotypic linkage of AMPK and TORC1, it is likely that AMPK
also receives inputs independently of TORC1/S6K to influence
life span. In support of this idea, AMPK has been proposed to
partially mediate the life span extension observed in the long-
lived C.elegans daf-2 mutant (Apfeld et al., 2004). Furthermore,460 Cell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc.links between AMPK and the ILS pathway have been demon-
strated by the finding that human andwormAMPK directly phos-
phorylates the FOXO transcription factor. DAF-16, the worm or-
tholog of FOXO, is required for the life span extension by
activation of AMPK (Greer et al., 2007) and also the maximal
life span extension by DR in some, but not all, DR regimes in
C. elegans (Greer and Brunet, 2009).
The regulation of the stress-responsive transcription factor
HIF-1a is under the control of TORC1 activity at both transcrip-
tional and translational levels (Bernardi et al., 2006; Hui et al.,
2006). This idea is supported by findings in cell culture studies
showing that rapamycin-treated cells fail to adapt to hypoxia
(Thomas et al., 2006). Low oxygen concentration results in the
stabilization of the transcription factor HIF-1a and the activation
of the hypoxic response (Kaelin and Ratcliffe, 2008). HIF-1a
helps cells adapt to low oxygen stress by regulating angiogen-
esis, glycolysis, and cell survival (Semenza, 2000). A recent
study suggests that in addition to being responsive to oxygen
levels, HIF-1 is also responsive to nutrients and mediates the
effects of DR on life span extension in C. elegans. Genetic epis-
tasis analysis places HIF-1 downstream of S6K to mediate life
span extension. A mutation in hif-1 extends life span on rich
nutrient conditions but does not cause further life span extension
under DR, whereas the egl-9mutant, with elevated HIF-1, fails to
show maximal life span extension under DR. Thus, there is an
inverse correlation between HIF-1 activities and life span, sug-
gesting that maximal life span extension by DR is mediated by
HIF-1 in C. elegans (Chen et al., 2009b). This study also found
that HIF-1 activity in muscle and specific neurons was critical
for mediating its effects on DR (Chen et al., 2009b). Interestingly,
an increase in HIF-1 levels inC. elegans has also been implicated
in life span extension, although by mechanisms distinct from DR
(Mehta et al., 2009; Zhang et al., 2009). The reasons for this
remain unclear (Kaeberlein and Kapahi, 2009) but may involve
the action of HIF-1 in different tissues for its differential effects
on life span. These findings open a new area of investigation to
examine the link between nutrients, oxygen tension, cancer,
and aging.
In yeast, TORC1 inhibition leads to enhanced resistance to
stress and nuclear translocation of Msn2, a stress-induced
transcription factor (Powers et al., 2006). Msn2/4 was also found
to be translocated to the nucleus and to contribute to life span
extension upon inhibition of TOR by enhancing the levels of
the nicotinamidase gene, PNC1 (Medvedik et al., 2007). The
serine/threonine kinase Rim15 positively regulates the stress
response transcription factors Gis1 and Msn2/4 and is required
for yeast CLS extension caused by deficiencies in Tor1, Sch9,
and by DR. A recent study in S. cerevisiae also found that DR
and inhibition of the TOR pathway enhances stress resistance
by switching metabolism to enhance glycerol synthesis (Wei
et al., 2009). Deletion of the glycerol biosynthesis genes that
were upregulated in long-lived TOR pathway mutants was
sufficient to reverse the CLS extension and enhanced stress
resistance, suggesting that glycerol production mediates the
enhanced stress resistance and increased CLS in yeast (Wei
et al., 2009). Together, these experiments support the idea that
inhibition of TORC1 plays an important role in mediating the
switch of cellular resources from growth and reproduction
toward somatic maintenance and life span extension.
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Autophagy is defined as a highly regulated cellular starvation
response to maintain essential nutrient levels and viability.
During macroautophagy, various cytoplasmic components,
including organelles, are enclosed within a double-membrane
structure (the autophagosome) and delivered to the vacuole (in
S. cerevisiae) or lysosome (in other eukaryotic cells) for degrada-
tion and recycling of the degradation products (Cecconi and
Levine, 2008; Diaz-Troya et al., 2008). The role of autophagy in
modulating life span was first identified when the extended life
span of the C.elegans mutant in daf-2, which encodes an
insulin-like receptor, was significantly abrogated by inhibition
of the autophagy gene bec-1 (Melendez et al., 2003). As inhibi-
tion of autophagy does not compromise the life span of control
animals in both worms and flies (Hansen et al., 2008; Melendez
et al., 2003; Ren et al., 2009), this observation supports the
idea that enhanced autophagy may extend life span. Inhibition
of TORC1 enhances autophagy and provides an attractive
mechanism to explain the effects of reduced TORC1 activity
on life span. In fact, autophagy is also required for the life span
extension mediated by DR or inhibition of TORC1 (Hansen
et al., 2008; Toth et al., 2008). Additionally, life span extension
by the eat-2mutation can be suppressed by inhibition of autoph-
agy genes using RNAi (Hansen et al., 2008; Jia and Levine, 2007).
Increased autophagy has been observed under DR and requires
the FOXA transcription factor PHA-4 (Hansen et al., 2008), which
is also a critical regulator of life span extension mediated by DR
(Panowski et al., 2007) and in S6Kmutants (Sheaffer et al., 2008).
Together these experiments implicate an important role for
autophagy in life span extension by DR. Future experiments
examining the role of autophagy in specific tissues will be
especially useful to our understanding its effects on life span.
Endoplasmic Reticulum Stress
ER stress is caused by amismatch between the load of unfolded/
misfolded proteins within the ER and the capacity of the cellular
machinery to cope with it (Ron and Walter, 2007). An increase in
ER stress and activation of the unfolded protein response (UPR)
in mammalian cells has been observed in response to excess
nutrients (Ozcan et al., 2004) or enhanced TORC1 signaling due
to loss of TSC1 or TSC2 (Ozcan et al., 2008). Genes that help
cope with ER stress have been shown tomediate life span exten-
sion in both S. cerevisiae (Steffen et al., 2008) and C. elegans
(Chen et al., 2009b). One possibility is that GCN4,whichmediates
the life span extension effects of DR, enhances survival bymodu-
lating ER signaling (Steffen et al., 2008). This is supported by the
findings thatGCN4hasbeenshown to regulateanumberofgenes
required forUPR inS.cerevisiae (Patil et al., 2004).Consistentwith
a role for the ER signaling pathway in C. elegans aging, ire-1was
found to be required for life span determination by DR and by loss
of hif-1 function (Chen et al., 2009b). IRE-1 is an ER transmem-
brane protein with kinase and RNase activities, which senses
misfolded proteins in the ER lumen and responds by splicing
the xbp-1 mRNA. This allows the translation of functional XBP-1
protein which regulates target genes required for increased ER
stress resistance (Ron and Walter, 2007). These studies open
a rich area of investigation to examine the mechanisms by which
ER stress signaling, which has been linked with obesity and
diabetes, mediates DR-dependent life span extension.Metabolism
DR has significant effects on metabolism, which has been
suggested to modulate the rate of aging (Masoro, 2003). Two
studies have shown that increased mitochondrial function either
by inhibition of TORC1 or by DR contributes to the life span
extension in S. cerevisiae and D. melanogaster. This is a sur-
prising finding, given that it is widely believed that enhanced
mitochondrial function would result in increased oxidative
damage by reactive oxygen species (ROS). The first study
proposes that deletion of the TOR1 gene extends CLS in
S. cerevisiae by increasing mitochondrial respiration via
enhanced translation of mtDNA-encoded oxidative phosphory-
lation complexes (Bonawitz et al., 2007). The increased CLS
upon deletion of TOR1 was reversed by inhibition of ETC
function. The second study showed that in D. melanogaster,
DR causes increased translation of nuclear-encoded mitochon-
drial genes, encoding for ETC and ribosomal proteins, thereby
enhancing mitochondrial density and function (Zid et al., 2009).
The role of mitochondrial function in mediating life span exten-
sion in D. melanogaster was confirmed by the observation that
inhibition of complex I throughout the whole body abrogated
the life span extension by DR (Zid et al., 2009).
These observations suggest that the translational regulation of
mitochondrial function and its protective effects during DR may
be conserved in different species. Surprisingly, and in contrast to
these findings, it has been observed that in C. elegans inhibition
of components of the ETC also lead to life span extension (Agui-
laniu et al., 2005). These observations are counterintuitive to the
proposed idea that a deficiency of ETC function with age,
observed in multiple species, may be responsible for organismal
aging (McCarroll et al., 2004). One possible explanation recon-
ciling these contradictory findings is that life span extension by
reduction of ETC function is tissue specific. In support of this
idea, it has recently been shown that inhibition of ETC in neurons
can extend life span even in D. melanogaster (Copeland et al.,
2009). Hence, it is conceivable that age-related decline in
mitochondrial function may contribute to aging by action in
nonneuronal tissues.
An outstanding question is that of how increased reliance on
mitochondrial respiration extends life span. The activity level of
TORC1 might regulate the switch between glycolysis and mito-
chondrial respiration for the generation of ATP. Highly active
TORC1 promotes high levels of HIF-1, shifting the cell toward
glycolysis. In contrast, TORC1 inhibition favors mitochondrial
ATP generation. The subsequent increase in mitochondrial
oxygen consumption might actually limit intracellular oxygen
and ROS-mediated damage associated with aging (Bonawitz
et al., 2007). Alternatively, the enhanced translation of mitochon-
drial ETC genes serves as a protective mechanism not only by
increasing mitochondrial efficiency but also by maintaining the
function of the ETC and, hence, ATP production, which is known
to decline with age (McCarroll et al., 2004). The shift of cancer
cells away from mitochondrial respiration toward glycolysis for
ATP generation even in the presence of oxygen has been termed
the Warburg effect (Warburg, 1956). A causal role for mitochon-
drial respiration in tumorigenesis is supported by findings that
succinate dehydrogenase and fumarate hydratase are tumor
suppressor genes (King et al., 2006). However, future work in
this area is required to identify the mechanisms by which theCell Metabolism 11, June 9, 2010 ª2010 Elsevier Inc. 461
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and cancer progression.
Summary and Future Outlook
We have summarized the ample evidence for the role of nutrient
and stress sensing by the TOR signaling network in mediating
responses to DR. Strong evidence supports a regulatory role
for reduced TOR signaling network activity to extend life span,
as this is observed in all model organisms tested so far (Figure 2).
This provides a strong framework and excellent tools for
exploring the link between nutrient limitation and life span exten-
sion. A conserved role for many components of this network
including TOR, S6K, and AMPK is emerging. This body of work
provides an array of excellent putative drug targets for extending
life span and slowing age-related diseases.
However, future work in this area examining the role of
different types of nutrients in various species to modulate life
span is needed to better assess the role of TOR in life span
extension by DR. Furthermore, it remains to be seen which
downstream effectors of TOR are key drivers of the longevity
phenotype and which ones elicit only minor effects. The role of
various tissues and their communication to determine organ-
ismal life span also remain poorly understood. Moreover, a
number of pathways that modulate aging are being discovered
which display effects on life span seemingly independent of
TORC1. The central challenge of aging research remains to flesh
out a unified picture of mechanisms determining aging. Further
analyses of TOR and other conserved pathways will shed light
on the link between diet and various age-related diseases such
as cancer, neurodegeneration, and diabetes in humans.
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